| 摘要 |
Oxygen-treatment (M1) of liquid unsaturated 6-26C compounds involves: (i) passing mixture of ozone and oxygen gas (O 2) through liquid material (LiqM) in reaction mixture chamber (RxnMC) at 40[deg]C; (ii) measuring temperature (t) of LiqM; (iii) continuing passage until measured (t) has reached maximum value; and (iv) controlling (t) in RxnMC during passage of LiqM below 100[deg]C by reducing rate of flow of LiqM. Oxygen-treatment (M1) of liquid unsaturated 6-26C compounds involves: (i) passing a mixture of ozone and oxygen gas (O 2) through the liquid material (LiqM) in a reaction mixture chamber (RxnMC) at 40[deg]C; (ii) continuously measuring the temperature (t) of LiqM; (iii) continuing the passage until the measured (t) has reached a maximum value; and (iv) controlling (t) in RxnMC during the passage of LiqM below 100[deg]C (preferably 80[deg]C) by reducing the rate of flow of LiqM. Independent claims are also included for the following: (1) a composition (C1) for therapeutic, veterinary and cosmetic application comprises: (a) hydroxyproline (less than 10 mass.%), and (b) a carrier material prepared according to (M1) (less than 20 mass.%); and (2) an apparatus for carrying out (M1) comprises: (a) a high voltage ozonizer (6) having a regulated ozone outflow line, (b) a reaction chamber (11) having an inflow and an outflow duct and a filter element permeable for the inflowing gas but non-permeable for O 2; (c) gas pump (13) coupled to the outflow duct of (11); (d) thermometer (12) for measuring (t) of O 2; and (e) a temperature regulator connected to (12) and coupled to (6) to reduce or cut off gas supply if (t) exceeds a pre-determined maximum. The inflow duct is connected to the outflow line of (6). (11) contains the LiqM. |
